I can only base my comment on what I read in announcements and...

I can only base my comment on what I read in announcements and comments from ACW. I think we will be heading to another trial with either the same dose or higher dose with longer treatment period. Phase II trial, we already know the results there, Xanahes trial is safe at higher dose with exploratory cognitive tests (NZ trader?). Target occupancy availing Researchers xanamens inhibition of cortisol at various doses in the brain. It would be interesting if results in this study showed improvement in brain volume or plaque removal in those patients with Alzheimers. Don't know if this study is that in-depth. As far as finance I don't know if BVF will come to the party with additional funds? One would think there would be continuing conversation between ACW management and Pharma. Share price I would be relieved to get back to my entry price of 5 cents but don't see that happening unless tomorrows announcement says the cortisol hypothesis is confirmed. Best of luck everyone.